Author: Li, Xinyu; Huang, Lei; Gao, Weijie
Title: Overexpression of Tripartite Motif Conaining 55 (TRIM55) Inhibits Migration and Invasion of Hepatocellular Carcinoma (HCC) Cells via Epithelial-Mesenchymal Transition and Matrix Metalloproteinase-2 (MMP2) Document date: 2019_1_27
ID: 037d5r9i_1
Snippet: Hepatocellular carcinoma (HCC) is a common digestive system tumor which has high morbidity and mortality rates [1] . Current treatments, including surgical resection, liver transplantation, and local ablation, are effective for early-stage HCC patients. However, patients with advanced HCC have early occurrence and poor prognosis, even when receiving the above treatments [2] . Thus, more predictive biomarkers are needed to improve postoperative ou.....
Document: Hepatocellular carcinoma (HCC) is a common digestive system tumor which has high morbidity and mortality rates [1] . Current treatments, including surgical resection, liver transplantation, and local ablation, are effective for early-stage HCC patients. However, patients with advanced HCC have early occurrence and poor prognosis, even when receiving the above treatments [2] . Thus, more predictive biomarkers are needed to improve postoperative outcomes in liver cancer patients.
Search related documents:
Co phrase search for related documents- advanced HCC patient and hcc patient: 1
- advanced HCC patient and Hepatocellular carcinoma: 1
- cancer patient and current treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9
- cancer patient and early stage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- cancer patient and HCC Hepatocellular carcinoma: 1, 2
- cancer patient and Hepatocellular carcinoma: 1, 2, 3
- cancer patient and high morbidity: 1, 2
- cancer patient and liver cancer patient: 1, 2, 3, 4, 5, 6
- cancer patient and liver transplantation: 1
- cancer patient and mortality high morbidity: 1, 2
- cancer patient and mortality high morbidity rate: 1
- cancer patient and poor prognosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- cancer patient and postoperative outcome: 1
- current treatment and early stage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- current treatment and HCC Hepatocellular carcinoma: 1
- current treatment and Hepatocellular carcinoma: 1, 2, 3, 4
- current treatment and high morbidity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- current treatment and liver transplantation: 1, 2, 3
- current treatment and local ablation: 1
Co phrase search for related documents, hyperlinks ordered by date